drug

JIN-A02

Phase 2updated 3mo ago

by J Ints Bio Co Ltd

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying JIN-A02

phase2A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLCrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

JIN-A02

Phase 2updated 3mo ago

by J Ints Bio Co Ltd

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying JIN-A02

phase2A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLCrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

JIN-A02

indications

all catalysts(0)

Trials studying JIN-A02

News(0)

Report a data issue

comments(0)

JIN-A02

indications

all catalysts(0)

Trials studying JIN-A02

News(0)

Report a data issue

comments(0)